Portal de Periódicos da CAPES

Chronic, active Epstein-Barr virus infection

2000; Lippincott Williams & Wilkins; Volume: 7; Issue: 1 Linguagem: Inglês

10.1097/00062752-200001000-00011

1531-7048

Diane M. Maia, Amy L Peace-Brewer,

Lymphoma Diagnosis and Treatment

Chronic active Epstein-Barr virus (EBV) infection is an uncommon outcome of EBV infection and may present as a waxing and waning or fulminant syndrome. Unlike acute infectious mononucleosis, wherein EBV establishes lifelong infection and survives by maintaining a delicate balance with the host as a latent infection, in chronic active EBV infection the host-virus balance is disturbed. The mechanisms by which this balance becomes perturbed are likely to be heterogenous and may involve host immune factors, viral factors, or both. A number of subtle immunologic defects have been reported in patients with chronic active EBV infection. Enhanced expression of viral genes has also been noted in some cases. Treatment of chronic active EBV infection has proven difficult, but new modalities including etoposide-based regimens and adoptive transfer of EBV-specific cytotoxic T lymphocytes have shown promise.